Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 2808)

Temuco, Araucania 4810218

0 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms

Studies at this site

• Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) — Completed